Literature DB >> 9118407

Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract.

E I Engelmyer1, J A Belis.   

Abstract

Nephrouterectomy, or partial uterectomy, is the treatment of choice for transitional cell carcinoma (TCC) of the upper urinary tract. However, patients with solitary kidneys, bilateral tumors, renal insufficiency, or medical comorbidities require more conservative management. When the TCC is low grade, it would be desirable to manage such tumors endoscopically. Ten patients with low-grade TCC of the upper urinary tract have been managed for 2-6 years with ureteroscopy and electrofulguration or laser coagulation. All tumors have been managed successfully without evidence of progression. Recurrence is frequent in some patients and requires repeat treatment and vigilant surveillance.

Entities:  

Mesh:

Year:  1996        PMID: 9118407

Source DB:  PubMed          Journal:  Tech Urol        ISSN: 1079-3259


  8 in total

Review 1.  Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.

Authors:  Julia V Fiuk; Brad F Schwartz
Journal:  World J Nephrol       Date:  2016-03-06

Review 2.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Authors:  Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin
Journal:  World J Urol       Date:  2016-05-27       Impact factor: 4.226

3.  Early repeated ureteroscopy within 6-8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings.

Authors:  Luca Villa; Jonathan Cloutier; Julien Letendre; Achilles Ploumidis; Andrea Salonia; Jean-Nicolas Cornu; Francesco Montorsi; Olivier Traxer
Journal:  World J Urol       Date:  2015-12-23       Impact factor: 4.226

Review 4.  Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience.

Authors:  Harun Fajkovic; Tobias Klatte; Udo Nagele; Michael Dunzinger; Richard Zigeuner; Wilhelm Hübner; Mesut Remzi
Journal:  World J Urol       Date:  2012-09-27       Impact factor: 4.226

Review 5.  Risk-adapted strategy for the kidney-sparing management of upper tract tumours.

Authors:  Thomas Seisen; Pierre Colin; Morgan Rouprêt
Journal:  Nat Rev Urol       Date:  2015-02-24       Impact factor: 14.432

Review 6.  Lasers in the upper urinary tract for non-stone disease.

Authors:  Courtney K Phillips; Jaime Landman
Journal:  World J Urol       Date:  2007-06-12       Impact factor: 3.661

Review 7.  Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up.

Authors:  Mudhar N Hasan; Morgan Rouprêt; Francis Keeley; Cecilia Cracco; Robert Jones; Michael Straub; Olivier Traxer; Palle Jörn Sloth Osther; Marianne Brehmer
Journal:  World J Urol       Date:  2019-04-03       Impact factor: 4.226

Review 8.  Minimally invasive management of upper tract urothelial carcinoma.

Authors:  Fadi N Joudi; Curtis N Crane; Michael A O'Donnell
Journal:  Curr Urol Rep       Date:  2006-01       Impact factor: 2.862

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.